|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0400 CAD | 0.00% |
|
+33.33% | -38.46% |
| Market Cap | 3.09M 2.22M 1.92M 1.79M 1.64M 211M 3.14M 21.04M 8.26M 106M 8.34M 8.15M 350M | P/E 2024 |
-9.02x | P/E 2025 | -2.81x |
|---|---|---|---|---|---|
| Enterprise Value | 3.27M 2.34M 2.03M 1.89M 1.74M 223M 3.32M 22.22M 8.72M 112M 8.8M 8.61M 370M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
84.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +33.33% | ||
| Current month | +33.33% | ||
| 1 month | -11.11% | ||
| 3 months | +33.33% | ||
| Current year | -38.46% |
| 1 week | 0.04 |  | 0.04 |
| 1 month | 0.03 | | 0.04 |
| Current year | 0.03 | | 0.1 |
| 1 year | 0.02 | | 0.13 |
| 3 years | 0.02 | | 0.2 |
| 5 years | 0.02 | | 0.95 |
| 10 years | 0.02 | | 4.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Roberto Fia
CEO | Chief Executive Officer | 55 | - |
Sung Min Myung
DFI | Director of Finance/CFO | 40 | 2019-10-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Roberto Fia
BRD | Director/Board Member | 55 | 2014-11-09 |
Andrew Peterson
CHM | Chairman | 78 | - |
Steve Naraine
BRD | Director/Board Member | - | 2023-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/1/25 | Sell | Chief Executive Officer | 375,000 | 0.8209% | ||
| 12/1/25 | Buy | Chief Executive Officer | 2,000 | 0.0044% | ||
| 12/1/25 | Buy | Chief Executive Officer | 171,000 | 0.3743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +33.33% | -33.33% | -20.00% | 2.2M | |
| +0.14% | -3.77% | -9.29% | -6.26% | 13.4B | |
| -0.84% | -3.33% | +4.09% | +6.37% | 5.09B | |
| +0.85% | -4.72% | -31.73% | -54.46% | 5.04B | |
| +4.49% | +2.16% | +4.81% | -31.02% | 4.02B | |
| -4.39% | -3.82% | -3.29% | +3.39% | 3.7B | |
| +0.84% | -2.92% | -9.10% | -4.42% | 3.66B | |
| +1.48% | -1.01% | -4.20% | +12.93% | 3.43B | |
| +3.37% | +2.11% | -11.98% | -21.70% | 2.41B | |
| +0.23% | -5.28% | -3.72% | +48.27% | 1.85B | |
| Average | +0.62% | +1.41% | -9.77% | -6.69% | 4.26B | |
| Weighted average by Cap. | +0.48% | -2.40% | -7.98% | -8.76% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -388K -278K -241K -225K -206K -26.5M -394K -2.64M -1.04M -13.28M -1.05M -1.02M -43.92M | -1.06M -764K -661K -617K -566K -72.69M -1.08M -7.24M -2.84M -36.43M -2.87M -2.81M -120M |
| Net Debt | 68.01K 48.8K 42.21K 39.42K 36.16K 4.64M 69.09K 462K 182K 2.33M 183K 179K 7.7M | 174K 125K 108K 101K 92.48K 11.88M 177K 1.18M 464K 5.95M 469K 458K 19.68M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | $0.0400 | +33.33% | 70,140 |
| 26-07-31 | $0.0300 | 0.00% | 1,599 |
- Stock Market
- Stocks
- CVGR Stock
Select your edition
All financial news and data tailored to specific country editions
